☆ 4.7 Editorial Material

Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can... Now We Need to Start Pulling! COMMENT

CLINICAL INFECTIOUS DISEASES (2021)

Get Full Text
Add to Collection

Journal

CLINICAL INFECTIOUS DISEASES
Volume 73, Issue 11, Pages E4451-E4453

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa852

Keywords

antibacterial agents; antibiotic resistance; antibiotic innovation; FDA

Categories

Immunology Infectious Diseases Microbiology

Funding

  1. Social Innovation in Drug Resistance Program at Boston University
  2. School of Law, both at Boston University

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.